EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

How renal toxins respond to renal function deterioration and oral toxic adsorbent in pH ‐controlled releasing capsule

Wen-Sheng Liu, Shih-Shin Liang, Mei-Mei Cheng, Ming-Tsan Wu, Szu-Yuan Li, Tien-Tien Cheng, Tsung-Yun Liu iD, Ching-Yao Tsai, Yen-Ting Lai, Chien-Hung Lin, Hsiang-Tsui Wang, Han-Hsing Tsou iD

Environmental Toxicology · 2024

DOI: 10.1002/tox.24248 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Environmental Toxicology, 2024. Verfasst von Wen-Sheng Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, Taipei City Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Glomerular Filtration Rate. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Taipei City Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The number of patients with chronic kidney disease (CKD) is increasing. Oral toxin adsorbents may provide some value. Several uremic toxins, including indoxyl sulfate (IS), p‐cresol (PCS), acrolein, per‐ and poly‐fluoroalkyl substances (PFAS), and inflammation markers (interleukin 6 [IL‐6] and tumor necrosis factor [TNF]‐alpha) have been shown to be related to CKD progression. A total of 81 patients taking oral activated charcoal toxin adsorbents (AC‐134), which were embedded in capsules that dissolved in the terminal ileum, three times a day for 1 month, were recruited. The renal function, hemoglobulin (Hb), inflammation markers, three PFAS (PFOA, PFOS, and PFNA), and acrolein were quantified. Compared with the baseline, an improved glomerular filtration rate (GFR) and significantly lower acrolein were noted. Furthermore, the CKD stage 4 and 5 group had significantly higher concentrations of IS, PCS, IL‐6, and TNF but lower levels of Hb and PFAS compared with the CKD Stage 3 group at baseline and after the intervention. Hb was increased only in the CKD Stage 3 group after the trial ( p = .032). Acrolein did not differ between the different CKD stage groups. Patients with improved GFR (responders) (about 77%) and nonresponders had similar baseline GFR. Responders had higher acrolein and PFOA levels throughout the study and a more significant reduction in acrolein, indicating a better digestion function. Both the higher PFOA and lower acrolein may be related to improved eGFR (and possibly to improvements in proteinuria, which we did not measure. Proteinuria is associated with PFAS loss in the urine), AC‐134 showed the potential to improve the GFR and decrease acrolein, which might better indicate renal function change. Future studies are needed with longer follow‐ups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicGlomerular Filtration RateHumansMaleFemaleAgedMiddle AgedCresolsAcroleinAdsorptionUremic ToxinsHydrogen-Ion ConcentrationIndicanCharcoalKidneyCapsulesAdministration, Oral

Stichwörter der Autor:innen

acroleinactivated charcoalchronic kidney disease (CKD)indoxyl sulfateoral toxin adsorbentsper‐and poly‐fluoroalkyl substances (PFAS)p‐cresol

Substanzen

CresolsAcroleinUremic ToxinsIndicanCharcoalCapsules

Autor:innen und Institutionen

  • Division of Nephrology, Department of Medicine, Taipei City Hospital, Taipei, Taiwan.
  • School of Medicine, National Yang Ming Chiao Tung University, Hsinchu, Taiwan.
  • College of Science and Engineering, Fu Jen Catholic University, New Taipei City, Taiwan.
  • Institute of Food Safety and Health Risk Assessment, National Yang Ming Chiao Tung University, Hsinchu, Taiwan.
  • Department of Special Education, University of Taipei, Taipei, Taiwan.
  • Institute of Biomedical Science, College of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan.

ORCID-Profile: Tsung-Yun Liu, Han-Hsing Tsou

Förderung

  • Taipei City Hospital

Zitieren

APA

Liu, W. S., Liang, S. S., Cheng, M. M., Wu, M. T., Li, S. Y., Cheng, T. T., Liu, T. Y., Tsai, C. Y., Lai, Y. T., Lin, C. H., Wang, H. T., & Tsou, H. H. (2024). How renal toxins respond to renal function deterioration and oral toxic adsorbent in pH ‐controlled releasing capsule. Environmental Toxicology. https://doi.org/10.1002/tox.24248

Vancouver

Liu WS, Liang SS, Cheng MM, Wu MT, Li SY, Cheng TT, et al. How renal toxins respond to renal function deterioration and oral toxic adsorbent in pH ‐controlled releasing capsule. Environmental Toxicology. 2024. doi:10.1002/tox.24248

BibTeX
@article{Liu2024,
  author = {Liu, Wen-Sheng and Liang, Shih-Shin and Cheng, Mei-Mei and Wu, Ming-Tsan and Li, Szu-Yuan and Cheng, Tien-Tien and Liu, Tsung-Yun and Tsai, Ching-Yao and Lai, Yen-Ting and Lin, Chien-Hung and Wang, Hsiang-Tsui and Tsou, Han-Hsing},
  title = {How renal toxins respond to renal function deterioration and oral toxic adsorbent in pH ‐controlled releasing capsule},
  journal = {Environmental Toxicology},
  year = {2024},
  doi = {10.1002/tox.24248}
}
Kostenlos starten →